Argentine laboratory raises funds to develop Sputnik vaccine
Pharmaceutical company Laboratorios Richmond has raised US$85 million to develop Russia’s Sputnik V covid-19 vaccine in Argentina, launching a public offering that called on local counsel from Nicholson y Cano Abogados and Tavarone, Rovelli, Salim & Miani.
To read more
Subscribe to Latin Lawyer
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Latin Lawyer experts.